New Breakthrough For Alzheimer’s Found In An Unexpecting Source.

In a surprising turn of events, a newly published paper in Frontiers in Neuroscience by researchers at the Del Monte Institute for Neuroscience at the University of Rochester found that glatiramer acetate, a commercially used drug for multiple sclerosis (MS) treatment exhibited memory improvement in a mouse model of Alzheimer's disease. Researchers found changes in the microglia -- part of the brain's immune system -- and improvements in cognitive behavior when glatiramer acetate was administered. These changes were due to less amyloid plaques and modifications to the tau pathology -- a protein found in neurodegenerative diseases -- indicating that the molecular hallmarks of Alzheimer's disease had been impacted. "This isn't a cure, but it could be a step in the right direction for a treatment to slow the symptoms of this debilitating disease." said M. Kerry O'Banion, M.D., Ph.D., professor of Neuroscience and senior author of the study. 

Read more here
Credits: ScienceDaily

Article Review from SUSMI Newsletter Issue: 11 (8/11/21)